Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenging boundaries: is cross-protection evaluation necessary for African swine fever vaccine development? A case of oral vaccination in wild boar

1 Oct 2024

Abstract excerpt

African swine fever (ASF) poses a significant threat to domestic pigs and wild boar (Sus scrofa) populations, with the current epidemiological situation more critical than ever. The disease has spread across five continents, causing devastating losses in the swine industry. Although extensive research efforts are ongoing to develop an effective and safe vaccine, this goal remains difficult to achieve. Among the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39411716
DOI: 10.3389/fimmu.2024.1388812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenging boundaries: is cross-protection evaluation necessary for African swine fever vaccine development? A case of oral vaccination in wild boarPMID 39411716Read ↗

First Oral Vaccination of Eurasian Wild Boar Against African Swine Fever Virus Genotype IISemantic proximity Read ↗

Live Attenuated African Swine Fever Viruses as Ideal Tools to Dissect the Mechanisms Involved in Cross-Protection.Semantic proximity Read ↗

Recent progress and major gaps in the vaccine development for African swine feverSemantic proximity Read ↗

Double Deletion of EP402R and EP153R in the Attenuated Lv17/WB/Rie1 African Swine Fever Virus (ASFV) Enhances Safety, Provides DIVA Compatibility, and Confers Complete Protection Against a Genotype II Virulent StrainSemantic proximity Read ↗

Thoughts on the research of African swine fever live-attenuated vaccinesSemantic proximity Read ↗

African swine fever vaccine: Turning a dream into realitySemantic proximity Read ↗

Approaches and Perspectives for Development of African Swine Fever Virus VaccinesSemantic proximity Read ↗

Current status and evolving approaches to African swine fever vaccine developmentSemantic proximity Read ↗

African Swine Fever Virus: A ReviewSemantic proximity Read ↗

Comparison of Genotype II African Swine Fever Virus Strain SY18 Challenge Models.Semantic proximity Read ↗

Genetic Variations of African Swine Fever Virus: Major Challenges and Prospects.Semantic proximity Read ↗

Attenuated African swine fever viruses and the live vaccine candidates: a comprehensive reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.